alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 7,226–7,250 of 7,816 matching trials · page 290 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
A Study to Evaluate Sleep Quality in Patients With Mild to Moderate Alzheimer's Disease
NCT01478204 		NA
other		 COMPLETED 925 Janssen-Cilag, S.A.
INDUSTRY		 2012-10-31
Study to Evaluate Safety, Tolerability, and Effect of AL208 on Mild Cognitive Impairment Following Coronary Artery Bypass Graft Surgery
NCT00404014
AL-208; Placebo
Runs in: Canada; United States · 28 sites 		PHASE2
other		 COMPLETED 234 Allon Therapeutics
INDUSTRY		 2012-10-24
Safety, Tolerability and Efficacy Study to Evaluate Subjects With Mild Cognitive Impairment
NCT00422981
AL-108; AL-108; Placebo
Runs in: United States · 17 sites 		PHASE2
other		 COMPLETED 144 Allon Therapeutics
INDUSTRY		 2012-10-24
The Prevalence of Neurocognitive Disorder in a Primary Care-based HIV Cohort Compared to a HIV-negative Control Cohort -
NCT01434563 		NA
other		 COMPLETED 326 Holdsworth House Medical Practice
OTHER		 2012-10-24
Exercise and Activities for Independent Living With Mild Cognitive Impairment (MCI)
NCT00446394
Resources and Activities for Life Long Independence (RALLI); Social...
Runs in: United States · 1 site 		NA
other		 COMPLETED 181 University of Washington
OTHER		 2012-10-19
DIetary Supplements, Executive funcTions and Vitamin D (DIET-D)
NCT01708005
Lecitone®Se-Vitamin D3; Placebo
Runs in: France · 1 site 		PHASE2|PHASE3
other		 UNKNOWN 160 University Hospital, Angers
OTHER_GOV		 2012-10-16
A Study to Compare Two Medications With an Inactive Medication and Look at the Effect on a Person's Mental Ability
NCT01126424
Solifenacin; Oxybutynin; Placebo
Runs in: United Kingdom · 3 sites 		PHASE4
other		 COMPLETED 26 Astellas Pharma Inc
INDUSTRY		 2012-10-15
Trazodone for Sleep Disorders in Alzheimer's Disease
NCT01142258
Trazodone; Placebo
Runs in: Brazil · 1 site 		PHASE3
other		 COMPLETED 40 Brasilia University Hospital
OTHER		 2012-10-15
PERDOVE ANZIANI: a Prospective Cohort Study on Older Patients
NCT01699984
Runs in: Italy · 4 sites 		NA
other		 COMPLETED 329 IRCCS Centro San Giovanni di Dio Fatebenefratelli
OTHER		 2012-10-04
Effects of Delivery Mode of Cognition Intervention in Early Alzheimer's Disease
NCT00611312
Cognitive Training
Runs in: United States · 1 site 		PHASE2
other		 COMPLETED 25 University of Kansas
OTHER		 2012-10-03
A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease
NCT00912288
Dimebon 20 mg po TID; Placebo po TID
Runs in: Canada; Germany; Hungary; Portugal; Slovakia; Spain; Turk... · 47 sites 		PHASE3
other		 TERMINATED 86 Pfizer
INDUSTRY		 2012-10-02
An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's Disease
NCT01066546
Dimebon tablet for oral administration
Runs in: United States · 5 sites 		PHASE3
other		 TERMINATED 5 Pfizer
INDUSTRY		 2012-10-02
Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease Patients
NCT01350362
tideglusib; tideglusib; tideglusib; Placebo
Runs in: Belgium; Finland; France; Germany; Spain; United Kingdom · 6 sites 		PHASE2
other		 COMPLETED 306 Noscira SA
INDUSTRY		 2012-10-02
The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD
NCT01696591
NEUROSTEM®-AD
Runs in: South Korea · 1 site 		NA
other		 UNKNOWN 14 Duk Lyul Na
OTHER		 2012-10-01
Clinical Research Center for Dementia of South Korea (CREDOS)(or CRCD)
NCT01198093
Runs in: South Korea · 1 site 		NA
other		 UNKNOWN 800 Samsung Medical Center
OTHER		 2012-09-28
Phase II Study for Amyloid Binding Imaging Study of [18F]AV-45 in Patients With Mild Cognitive Impairment, Alzheimer's Disease and Healthy Volunteers
NCT01238458
[18F]AV-45 PET amyloid binding imaging 		PHASE2
other		 UNKNOWN 150 Chang Gung Memorial Hospital
OTHER		 2012-09-28
Randomized Trial of Exercise and Social Interaction in a Community-Based Sample of Non-Demented Chinese Elders
NCT01696019
Fast walking; Tai Chi; Intellectual stimulation; Contact and testing only
Runs in: China · 1 site 		NA
other		 COMPLETED 120 University of South Florida
OTHER		 2012-09-28
Efficacy and Tolerability of MLC601 in Patients With Mild to Moderate Alzheimer Disease Who Were Unable to Tolerate or Failed to Benefit From Treatment With Rivastigmine
NCT01696123
MLC601
Runs in: Iran · 1 site 		PHASE2
symptomatic-cholinergic		 COMPLETED 125 Shahid Beheshti University of Medical Sciences
OTHER		 2012-09-28
Effect of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers
NCT01005862
PF-04360365; Placebo
Runs in: Sweden; United States · 3 sites 		PHASE1
other		 COMPLETED 17 Pfizer
INDUSTRY		 2012-09-26
Effect of LY2062430 on the Progression of Alzheimer's Disease
NCT00905372
LY2062430; Placebo
Runs in: Argentina; Brazil; Canada; Japan; United States · 85 sites 		PHASE3
other		 COMPLETED 1,000 Eli Lilly and Company
INDUSTRY		 2012-09-25
A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's
NCT01148498
solanezumab
Runs in: United States · 1 site 		PHASE2
anti-amyloid-antibody		 COMPLETED 55 Eli Lilly and Company
INDUSTRY		 2012-09-25
Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline
NCT00506415
Rivastigmine 5 cm^2; Rivastigmine 10 cm^2; Rivastigmine 15 cm^2; Pl...
Runs in: Canada; France; Germany; Italy; Spain; Switzerland; United States · 145 sites 		PHASE3
symptomatic-cholinergic		 COMPLETED 1,584 Novartis Pharmaceuticals
INDUSTRY		 2012-09-19
SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)
NCT00438568
Regular Insulin; Placebo
Runs in: United States · 1 site 		PHASE2
other		 COMPLETED 173 University of Washington
OTHER		 2012-09-14
Non-expensive and Widely Available Tests as Diagnostic Tools in Dementia and Their Ability to Predict Disease Progression
NCT01642420
Runs in: Denmark · 1 site 		NA
other		 UNKNOWN 115 Zealand University Hospital
OTHER		 2012-09-13
Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia
NCT01176721
t-VNS verum; t-VNS placebo
Runs in: Germany · 2 sites 		PHASE2
other		 COMPLETED 20 cerbomed GmbH
INDUSTRY		 2012-09-12

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →